Disease Detection Simplified

Gray downward chevron on white background

The most transformative solutions make things easier, faster, or more economical. Darwin’s point-of-care platform delivers on all three—offering a streamlined, effective tool for earlier detection and smarter disease management.

Welcome to our Lab

Darwin's breakthrough diagnostic device leverages a unique biomarker panel to detect the immune signature indicative of acute-phase infections.

Completely self-contained, it works independent of laboratories and even power sources. That means point-of-care can be anywhere.

Our non-invasive test delivers fast, accurate results and a critical advantage in clinical and operational settings.

Advanced Science Intuitive Experience

Illustration of a person using the saliva collection tip.
saliva collection tip being inserted into device

• Saliva Collection

• Swab Insertion

• Saliva Processing
• Heater Activation
• RNA Amplification

• Results Presentation

results readout
Saliva Processing, Heater Activation, RNA Amplification

Select Traits

Illustration of a teardrop-shaped object with circuit-like patterns and glowing nodes

Non-invasive

Uses saliva instead of blood for easier, patient-friendly sampling.


Broad Infection Detection

Identifies an immune response indicative of infection, regardless of pathogen type.


Scalable Platform

Adaptable for detecting nucleic acids relevant to various disease spaces.

Military Precision

Illustration of a soldier wearing tactical gear, including a helmet with a visor and night vision goggles, a headset with a microphone, tactical vest, and camouflage clothing.

Our technology originated from military-funded research aimed at developing rapid, field-deployable diagnostic solutions.

Historically, some of the most impactful medical advancements, such as trauma care techniques and prosthetic innovations, began in military settings before revolutionizing civilian healthcare. Building on this legacy, our platform offers a game-changing solution for both military and commercial markets.

The Power of Early Sepsis Detection

Human torso with visible organs, nerves, and circulatory system in a digital illustration.

Sepsis is a leading cause of mortality in hospitals worldwide, with delayed diagnosis often resulting in severe complications or death.

Every hour that a septic patient goes without treatment increases the risk of death by 8%.

Our technology addresses this critical challenge by providing early, reliable sepsis detection. It’s faster, more accessible and considerably less expensive than comparable tests.

This enables timely interventions that can save lives and reduce long-term complications.

Versatile Platform–Built for Strategic Partnerships

Flowchart illustrating various applications of pathogen detection in areas such as universal pathogen detection, direct pathogen detection, animal health, surveillance, oncology, environmental and industrial, and immunity monitoring.
Flowchart representing different applications of pathogen detection, including universal detection, direct detection, animal health, surveillance and preparedness, oncology, environmental and industrial monitoring, and immunity monitoring, with subcategories for each.
Infographic showing detection and monitoring categories including Universal Pathogen Detection, Direct Pathogen Detection, Animal Health, Surveillance & Preparedness, Oncology, Environmental and Industrial, and Immunity Monitoring.
  • Current Focus
  • Near-Term Growth
  • Future Potential

Explore our vision by phase:

Our diagnostic platform is designed to serve as a foundation for a wide range of applications. Companies developing POC molecular diagnostics in human and animal health can leverage our technology to develop targeted diagnostic solutions tailored to their respective markets.

From Sepsis to Ebola, Darwin technology is proving effective. We are at various stages of cinical development and are actively pursuing strategic partnerships.

Scientist examining test tubes with liquid samples, wearing gloves and protective eyewear.

Backstory

The following challenge from the US Government was the inspiration that launched Darwin Biosciences:

Limit disease outbreaks with an easy-to-use device that detects the presence of all known and unknown pathogens.

The company was founded in March of 2020, and pivoted directly into COVID-19 detection. Darwin's saliva-based solution was proven comparable to other tests and used thousands of times.

In the years since, Darwin has completed milestone after milestone and fulfilled our original mission. $17 million of investment has yielded a one-of-a-kind device that is trancending expectations.

Leadership

  • Portrait of a man with a mustache, wearing a gray button-up shirt, against a gray background.

    Nick Meyerson, Ph.D.

    CEO and CO-FOUNDER

    Evolution | Virology | Immunology

  • Smiling woman with long blonde hair in a black top against a gray background.

    Sara Sawyer, Ph.D.

    DIRECTOR and CO-FOUNDER

    Professor, CU Boulder

  • Smiling woman with brown hair in a bun wearing a white top against a gray background.

    Amy Emerman, Ph.D.

    DIRECTOR PRODUCT DEVELOPMENT

    Device Strategy | RNA

  • Smiling woman with short gray hair wearing a pink blouse and a pearl necklace against a gray background.

    Claire Alexander, B.S.N., M.B.A.

    VP CLINICAL AFFAIRS and OPERATIONS

    Study Design and Execution

Advisors

  • Portrait of an older man wearing a suit and dress shirt, looking at the camera.

    Byron Hewett, M.B.A.

    DIRECTOR

    CEO, General Inception

  • Portrait of a man in a suit and tie smiling

    Peter Bryant-Greenwood, M.D.

    MEDICAL ADVISOR

    CMO, Brazos Neuroscience

  • Smiling man in a white coat with a tie, professional portrait

    Micah McClain, M.D., Ph.D.

    MEDICAL ADVISOR

    Associate Professor, Duke University

  • A man with short dark hair and stubble wearing a checkered shirt and a jacket, smiling slightly, against a plain background.

    Daniel Larremore, Ph.D.

    SCIENTIFIC ADVISOR

    Associate Professor, CU Boulder

Catalysts

  • University of Colorado seal featuring a seated figure, torch, laurel wreath, and inscription "LET YOUR LIGHT SHINE" with year 1876.

  • Duke University seal with a laurel wreath and building illustration, blue background, established 1838.

  • Seal of the State University of New York Upstate Medical University featuring a caduceus symbol, laurel branches, and text reading "Education • Research • Health Care • Service."